5. 老化とカルシウム代謝
スポンサーリンク
概要
- 論文の詳細を見る
Measurements of bone mineral content (BMC), intestinal <SUP>47</SUP>Ca absorption, calcium regulating hormones, sex hormones and other hormones were performed on 32 healthy aged subjects (60y.o-85y.o) and 26 controls (15y.o-42y.o).<BR>In BMC, there was a progressive fall after age 40 in both sexes, with the rate of decrease being greater in women than in men, so that at age 70-80, BMC was only 70% of that seen at age 40 in males and 50% in females.<BR>There was a significant correlation between BMC and plasma testosterone levels in the men and between plasma estrogens and BMC in the women, suggesting that testosterone might play an important role in maintaining bone remodeling at the normal rate in males, whereas estrogens were important in females.<BR>Plasma PTH showed no change with age and sex. However, response of the parathyroid to EDTA infusion was significantly lower in the aged females than that seen in the aged males and the controls, indicating that the aged females were in an occult hypoparathyroid state. Basal plasma calcitonin levels were lower in the aged of both sexes than those in the controls. Response of C-cell to Ca infusion was also low, indicating that the C-cells function was reduced in the aged subjects.<BR>Plasma 1,25(OH)<SUB>2</SUB>D was reduced in the aged subjects, while plasma 25(OH)D levels were slightly high. It was speculated that the decrease in the conversion of 25-OH-D<SUB>3</SUB> to 1,25(OH)<SUB>2</SUB>D<SUB>3</SUB> might be an important factor in causing a decrease in the rate of mineral turnover in bone with age.<BR>In conclusion : aging and calcium metabolism is characterized by a chronic negative imbalance. This negative balance could be a reflection of a hormonal imbalance occurring with aging, and it would become more important to define these changes in order to devise both therapeutic and preventive measures.
- 日本内分泌学会の論文
著者
関連論文
- 破裂脳動脈瘤症例におけるポジトロンCTを用いた局所脳血流と脳代謝
- 中枢性ベンゾジアゼピン受容体イメージング剤^I-イオマゼニルの第3相臨床試験(第4報) : 脳血管障害における臨床的有用性の検討
- 中枢性ベンゾジアゼピン受容体イメージング剤^I-イオマゼニルの第3相臨床試験(第3報) : てんかんにおける臨床的有用性の検討
- 中枢性ベンゾジアゼピン受容体イメージング剤^I-イオマゼニルの第3相臨床試験(第2報) : 中枢神経変性疾患および精神神経障害における臨床的有用性の検討
- 中枢性ベンゾジアゼピン受容体イメージング剤^I-イオマゼニルの第3相臨床試験(第1報) : 各種脳疾患等における安全性および臨床的有効性の検討
- 核医学の現状と展望
- 核医学の現状と展望
- 放射線医療技術学叢書(9) : 核医学検査技術学入門, (社)日本放射線技術学会核医学分科会, 藤田 透・渡部洋一編, A4版, 128頁, 定価3,400円, 1995年
- ^I-ortho-iodo-hippurate (OIH) による腎シンチグラフィーの臨床的応用 : 第33回中部連合総会
- 中枢性ベンゾジアゼピン受容体イメージング剤 I-イオマゼニルの第2相臨床試験(第2報) : 各種脳疾患における臨床的有用性の検討
- 中枢性ベンゾジアゼピン受容体イメージング剤 ^I-イオマゼニルの第2相臨床試験(第1報) : 投与量および適応疾患の検討
- PTH (血液・尿・化学検査--その数値をどう読むか) -- (ホルモン)
- インドメサシン負荷試験 (現代臨床機能検査--その実際と解釈) -- (内分泌機能検査--副甲状腺機能)
- Calicitonin (合成Peptide HormoneとAnalogues--化学構造・作用・臨床応用-2完-)
- 5. 老化とカルシウム代謝